Induced sensitivity to EGFR inhibitors is mediated by palmitoylated cysteine 1025 of EGFR and requires oncogenic Kras

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (R01CA181633)
  • ACS (RSG-15-027-01)
  • Pennsylvania Department of Health

This publication has 18 references indexed in Scilit: